ACH
ACCENDRA HEALTH INC/VA/
Overview
Accendra Health provides home medical equipment, disposable supplies, and related services to patients with chronic and acute conditions through its Apria and Byram Healthcare brands.
ACCENDRA HEALTH INC/VA/ is a Healthcare company operating in Medical Distribution with a $247.4M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 9, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-118 Q&A exchanges
- Q4 FY2025Earnings2026-02-1917 Q&A exchanges
- Q3 FY2025Earnings2025-10-306 Q&A exchanges
- Q2 FY2025Earnings2025-08-1114 Q&A exchanges
- Q1 FY2025Earnings2025-05-0815 Q&A exchanges
- Q4 FY2024Earnings2025-02-2824 Q&A exchanges
- Q3 FY2024Earnings2024-11-0423 Q&A exchanges
- Q2 FY2024Earnings2024-08-0229 Q&A exchanges
- Q1 FY2024Earnings2024-05-0320 Q&A exchanges
- Q4 FY2023Earnings2024-02-2016 Q&A exchanges
- Q3 FY2023Earnings2023-11-0310 Q&A exchanges
- Q2 FY2023Earnings2023-08-0414 Q&A exchanges
- Q1 FY2023Earnings2023-05-0515 Q&A exchanges
- Q4 FY2022Earnings2023-02-2813 Q&A exchanges
- Q3 FY2022Earnings2022-11-029 Q&A exchanges
- Q2 FY2022Earnings2022-08-0313 Q&A exchanges
- Q1 FY2022Earnings2022-05-0325 Q&A exchanges
- Q4 FY2021Earnings2022-02-2313 Q&A exchanges
- Q3 FY2021Earnings2021-11-0318 Q&A exchanges
- Q2 FY2021Earnings2021-08-0319 Q&A exchanges
- Q1 FY2021Earnings2021-05-0525 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-09EPS— vs $-0.09—Rev— vs ——EODHD
- Q1 FY20262026-05-10EPS$-0.04 vs $-0.10+59.3%Rev$627.8M vs ——EODHD
- Q4 FY20252026-02-19EPS$0.21 vs $0.22-5.1%Rev$709.0M vs ——EODHD
- Q3 FY20252025-10-30EPS$0.25 vs $0.23+6.4%Rev$697.3M vs ——EODHD
- Q2 FY20252025-08-10EPS$0.26 vs $0.28-5.7%Rev$681.9M vs ——EODHD
- Q1 FY20252025-05-07EPS$0.23 vs $0.20+14.4%Rev$2.63B vs ——EODHD
- Q4 FY20242025-02-27EPS$-3.84 vs ——Rev$2.70B vs ——EODHD
- Q3 FY20242024-11-03EPS$-0.17 vs ——Rev$686.8M vs ——EODHD
- Q2 FY20242024-08-01EPS$-0.42 vs ——Rev$660.4M vs ——EODHD
- Q1 FY20242024-05-02EPS$-0.29 vs ——Rev$2.61B vs ——EODHD
- Q4 FY20232024-02-19EPS$0.23 vs ——Rev$2.66B vs ——EODHD
- Q3 FY20232023-11-02EPS$-0.08 vs ——Rev$2.59B vs ——EODHD
- Q2 FY20232023-08-03EPS$-0.37 vs ——Rev$2.56B vs ——EODHD
- Q1 FY20232023-05-04EPS$-0.32 vs ——Rev$2.52B vs ——EODHD
- Q4 FY20222023-02-27EPS$-0.77 vs ——Rev$2.55B vs ——EODHD
- Q3 FY20222022-11-01EPS$0.16 vs ——Rev$2.50B vs ——EODHD
- Q2 FY20222022-08-02EPS$0.37 vs ——Rev$2.50B vs ——EODHD
- Q1 FY20222022-05-03EPS$0.52 vs ——Rev$2.41B vs ——EODHD
- Q4 FY20212022-02-22EPS$0.55 vs ——Rev$2.47B vs ——EODHD
- Q3 FY20212021-11-02EPS$0.58 vs ——Rev$2.50B vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-09 | — | $-0.09 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-10 | $-0.04 | $-0.10 | +59.3% | $627.8M | — | — | EODHD |
| Q4 FY2025 | 2026-02-19 | $0.21 | $0.22 | -5.1% | $709.0M | — | — | EODHD |
| Q3 FY2025 | 2025-10-30 | $0.25 | $0.23 | +6.4% | $697.3M | — | — | EODHD |
| Q2 FY2025 | 2025-08-10 | $0.26 | $0.28 | -5.7% | $681.9M | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $0.23 | $0.20 | +14.4% | $2.63B | — | — | EODHD |
| Q4 FY2024 | 2025-02-27 | $-3.84 | — | — | $2.70B | — | — | EODHD |
| Q3 FY2024 | 2024-11-03 | $-0.17 | — | — | $686.8M | — | — | EODHD |
| Q2 FY2024 | 2024-08-01 | $-0.42 | — | — | $660.4M | — | — | EODHD |
| Q1 FY2024 | 2024-05-02 | $-0.29 | — | — | $2.61B | — | — | EODHD |
| Q4 FY2023 | 2024-02-19 | $0.23 | — | — | $2.66B | — | — | EODHD |
| Q3 FY2023 | 2023-11-02 | $-0.08 | — | — | $2.59B | — | — | EODHD |
| Q2 FY2023 | 2023-08-03 | $-0.37 | — | — | $2.56B | — | — | EODHD |
| Q1 FY2023 | 2023-05-04 | $-0.32 | — | — | $2.52B | — | — | EODHD |
| Q4 FY2022 | 2023-02-27 | $-0.77 | — | — | $2.55B | — | — | EODHD |
| Q3 FY2022 | 2022-11-01 | $0.16 | — | — | $2.50B | — | — | EODHD |
| Q2 FY2022 | 2022-08-02 | $0.37 | — | — | $2.50B | — | — | EODHD |
| Q1 FY2022 | 2022-05-03 | $0.52 | — | — | $2.41B | — | — | EODHD |
| Q4 FY2021 | 2022-02-22 | $0.55 | — | — | $2.47B | — | — | EODHD |
| Q3 FY2021 | 2021-11-02 | $0.58 | — | — | $2.50B | — | — | EODHD |
Source: EODHD. ACH reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks ACH's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.83 | $1.88 | -2.9% | +4.2% | +1.3% |
| Q4 FY2026 | $1.76 | $1.95 | -9.7% | -0.3% | -1.6% |
| Q3 FY2026 | $1.74 | $1.83 | -5.1% | -0.6% | -3.3% |
| Q2 FY2026 | $1.76 | $1.87 | -6.0% | -2.4% | -2.7% |
| Q1 FY2025 | $1.57 | $1.86 | -15.4% | -4.6% | -5.9% |
| Q4 FY2025 | $1.60 | $1.85 | -13.5% | -3.4% | -2.3% |
| Q3 FY2025 | $1.85 | $2.06 | -10.3% | -4.5% | -5.4% |
| Q2 FY2025 | $1.65 | $1.94 | -14.7% | -4.9% | -7.3% |
| Q1 FY2024 | $1.82 | $2.12 | -14.0% | +0.7% | -1.5% |
| Q4 FY2024 | $1.73 | $1.94 | -10.6% | +4.7% | +3.7% |
Guidance change history
Sample- Q1 FY2026Maintained2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Andrew G LongCEO1 yr 3 mo7 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • guidance suspended Q3 FY2026
- Edward A PesickaCEO1 yr 3 mo21 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • last call held guidance Q3 FY2026
- Perry A BernocchiCEO1 yr 3 mo2 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • last guidance cut Q3 FY2026
- Jonathan A LeonCFO1 yr 3 mo7 callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • last call held guidance Q3 FY2026
- Jennifer A StoneEVP, CHRO1 yrno recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • last guidance cut Q3 FY2026
- Heath H GallowayEVP,General Counsel & CorpSecy1 yr 3 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 1/4 beats (25%) • guidance suspended Q1 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ACH.
$ curl https://api.spokenalpha.com/v1/companies/ACHFAQ
Frequently asked about ACH
Where can I find ACCENDRA HEALTH INC/VA/'s (ACH) earnings call transcripts?
Spoken Alpha indexes ACH's earnings call transcripts at https://spokenalpha.com/companies/ACH. Each call links to attributed speakers and parsed analyst Q&A.
When was ACCENDRA HEALTH INC/VA/'s most recent earnings call?
ACCENDRA HEALTH INC/VA/ (ACH) held its most recent earnings call on 2026-05-11, covering fiscal Q1 2026.
What sector is ACH in?
ACCENDRA HEALTH INC/VA/ (ACH) operates in the Healthcare sector (Medical Distribution industry).